ITeos Therapeutics (ITOS) Competitor Comparison
We are evaluating the key criteria listed to compare ITeos Therapeutics (ITOS) against its competitors in the Biotechnology industry.
Market Capitalization
182 / 368Gross Profits
26 / 278Total Revenue
108 / 300EBITDA
193 / 337Free Cashflow
286 / 352Quick Ratio
22 / 357Earnings per Share
256 / 359Dividend yield
0 / 6Total Cash
48 / 358Performance 3 years
212 / 368Performance 5 years
205 / 368Performance 10 years
178 / 368Linearity 3 years
169 / 368Linearity 5 years
75 / 368Linearity 10 years
57 / 368Total Rank
167 / 368Dividend Rank
171 / 368Valuation Rank
76 / 368Piotroski Rank
204 / 368Muliplier Rank
35 / 368Performance 5 years - ITOS ranking 205 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.